The cyclin-dependent kinase pathway moves forward

Circulation Research

Volumn 92, Issue 4, 2003, Pages 345-347

  Bornfeldt, Karin E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclin dependent kinase inhibitor; Migration; Retinoblastoma protein; Smooth muscle cells

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; RETINOBLASTOMA PROTEIN;

CELL CYCLE; CELL MIGRATION; CELL MOTION; EDITORIAL; ENZYME ACTIVITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANIMALS; CELL ADHESION; CELL CYCLE PROTEINS; CELL DIVISION; CELL MOVEMENT; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYTOSKELETON; MUSCLE, SMOOTH, VASCULAR; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0037423880     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000061765.06145.10     Document Type: Editorial

References (29)

1. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13:1501-1512.
2. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998;12:2245-2262.
3. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-126.
4. Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation. 1998;98:82-89.
5. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell. 2001;104:503-516.
6. Grunwald J, Haudenschild CC. Intimal injury in vivo activates vascular smooth muscle cell migration and explant outgrowth in vitro. Arteriosclerosis. 1984;4:183-188.
7. Boehm M, Nabel EG. Cell cycle and cell migration: new pieces to the puzzle. Circulation. 2001;103:2879-2881.
8. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest. 1996;98:2277-2283.
9. Kip1 in vascular smooth muscle cell migration. Circulation. 2001;103:2967-2972.
10. Roque M, Reis ED, Cordon-Cardo C, Taubman MB, Fallon JT, Fuster V, Badimon JJ. Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model. Lab Invest. 2001;81:895-903.
11. Chang MW, Barr E, Lu MM, Barton K, Leiden JM. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest. 1995;96:2260-2268.
12. Kip1, an inhibitor of neointima formation in the rat carotid artery. J Clin Invest. 1997;99:2334-2341.
13. Ink4 on vascular smooth muscle cell proliferation. Circulation. 2000;101:2022-2025.
14. Condorelli G, Aycock JK, Frati G, Napoli C. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice. FASEB J. 2001;15:2162-2170.
15. Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 1995;267:518-522.
16. Kip1/cyclin-dependent kinase/retinoblastoma pathway in vascular smooth muscle cells and fibroblasts. Circ Res. 2003;92:402-410.
17. Kip1 in smooth muscle cells from different vascular beds: a potential role in establishing regional phenotypic variance. J Biol Chem. 2003;278:4482-4490.
18. Matsuyama J, Berman JS, Cruikshank WW, Morimoto C, Center DM. Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro. J Immunol. 1992;148:1367-1374.
19. Bonneton C, Sibarita JB, Thiery JP. Relationship between cell migration and cell cycle during the initiation of epithelial to fibroblastoid transition. Cell Motil Cytoskeleton. 1999;43:288-295.
20. 1 phase in cultured smooth muscle cells. Am J Physiol Cell Physiol. 2000;279:C999-C1007.
21. Kubens BS, Niggemann B, Zanker KS. Prevention of entrance into G2 cell cycle phase by mimosine decreases locomotion of cells from the tumor cell line SW480. Cancer Lett. 2001;162(suppl):S39-S47.
22. Burstyn-Cohen T, Kalcheim C. Association between the cell cycle and neural crest delamination through specific regulation of G1/S transition. Dev Cell. 2002;3:383-395.
23. Witzenbichler B, Kureishi Y, Luo Z, Le Roux A, Branellec D, Walsh K. Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor. J Clin Invest. 1999;104:1469-1480.
24. Geraldes P, Sirois MG, Bematchez PN, Tanguay JF. Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase. Arterioscler Thromb Vasc Biol. 2002;22:1585-1590.
25. Lake AC, Bialik A, Walsh K, Castellot JJ Jr. CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility. Am J Pathol. 2003;162:219-231.
26. Tulis DA, Mnjoyan ZH, Schiesser RL, Shelat HS, Evans AJ, Zoldhelyi P, Fujise K. Adenoviral gene transfer of fortilin attenuates neointima formation through suppression of vascular smooth muscle cell proliferation and migration. Circulation. 2003;107:98-105.
27. Cho A, Reidy MA. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res. 2002;91:845-851.
28. 3 to focal contacts. EMBO J. 1999;18:2106-2118.
29. Degertekin M, Regar E, Tanabe K, Smits PC, van der Giessen WJ, Carlier SG, de Feyter P, Vos J, Foley DP, Ligthart JM, Popma JJ, Serruys PW. Sirolimus-eluting stent for treatment of complex in-stent restenosis: The first clinical experience. J Am Coll Cardiol. 2003;41:184-189.